As TLR4 activation in myeloma cells suppresses ER stress, reducing the efficacy of BTZ [22], we evaluated herein the role of TLR4 signalling on MM cells’ mitochondrial dynamics and energy metabolism as the potentially active mechanism of drug resistance to BTZ. The gene discussed is TLR4; the disease is Miyoshi myopathy.